GPCR News 

Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1

Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...

Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...

A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in...

8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy

Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...

Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84

Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner

Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling

Amgen to Acquire Chemocentryx for $4 Billion in Cash

Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...

GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin...

Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...

Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di

The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor

G protein-coupled receptor 21 in macrophages: An in vitro study

MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?

Fusion protein strategies for cryo-EM study of G protein-coupled receptors

Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update

GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...